Brief: Aura Biosciences Reports Fourth Quarter Financial Results
March 23 (Reuters) - Aura Biosciences Inc AURA.O :
* AURA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS AND PROVIDES CLINICAL DEVELOPMENT AND
OPERATIONAL HIGHLIGHTS
* AURA BIOSCIENCES INC - BELIEVES ITS CURRENT CASH AND CASH
EQUIVALENTS ARE SUFFICIENT TO FUND ITS OPERATIONS INTO 2024
Source text for Eikon: ID:nBw60XvXFa
Further company coverage: AURA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs